CSF1R activation leads to the recruitment of CSF1R-expressing macrophages that constitute a large part of the tumor mass in dt-GCT, thus making this pathway an ideal therapeutic target for compounds interfering with the CSF1/CSF1R-signaling axis. This evidence concerns the gene CSF1R and granular cell tumor.